Bortezomib as a rescue therapy for hyperacute and multi-drug resistant mixed acute rejection after kidney transplantation

Clin Transpl. 2009:485-90.

Authors

Arjang Djamali¹, Brenda L Muth, Jose Torrealba, Debra Bloom, Karen M Miller, David Lorentzen, Hans W Sollinger, John D Pirsch, Joshua D Mezrich

Affiliation

¹ Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin, USA.

PMID: 20524320

No abstract available

Publication types

Case Reports

MeSH terms

Acute Disease
Adult
Boronic Acids / therapeutic use*
Bortezomib
Creatinine / urine
Diabetes Mellitus, Type 1 / surgery
Diabetic Nephropathies / surgery
Diuresis / drug effects
Drug Resistance, Multiple / drug effects*
Graft Rejection / drug therapy*
Graft Rejection / pathology
Humans
Immunization
Kidney Transplantation / immunology*
Kidney Transplantation / pathology
Male
Pancreas Transplantation
Protease Inhibitors / therapeutic use*
Pyrazines / therapeutic use*

Substances

Boronic Acids
Protease Inhibitors
Pyrazines
Bortezomib
Creatinine